Prognostic value of serum creatinine in non-ST-elevation acute coronary syndrome;Valor pronóstico de la creatinina sérica en el síndrome coronario agudo sin elevación del segmento ST

Revista Espanola de Cardiologia

Volumn 59, Issue 3, 2006, Pages 209-216

  Fácila, Lorenzo Rubio ^a,b   Núñez, Julio ^a   Bodí, Vicent ^a   Sanchís, Juan ^a   Bertomeu González, Vicente ^a   Consuegra, Luciano ^a   Pellicer, Mauricio ^a   Ferrero, Ángel ^a   Sanjuán, Rafael ^a   Llácer, Ángel ^a  

^a HOSPITAL CLÍNICO UNIVERSITARIO   (Spain)

^b HOSPITAL PROVINCIAL DE CASTELLÓN   (Spain)

Author keywords

Kidney failure; Myocardial ischemia; Prognosis

Indexed keywords

BIOCHEMICAL MARKER; CREATININE; MYOGLOBIN; TROPONIN I;

ACUTE CORONARY SYNDROME; ADULT; AGE; ARTICLE; CAUSE OF DEATH; CIGARETTE SMOKING; CONTROLLED STUDY; CORONARY ARTERY DISEASE; CORRELATION ANALYSIS; CREATININE BLOOD LEVEL; DIABETES MELLITUS; DIAGNOSTIC VALUE; DISEASE CLASSIFICATION; DISEASE MARKER; DYSLIPIDEMIA; FEMALE; FREQUENCY ANALYSIS; GENDER; GLOMERULUS FILTRATION RATE; HEART FAILURE; HOSPITAL ADMISSION; HUMAN; KIDNEY FAILURE; LINEAR SYSTEM; MAJOR CLINICAL STUDY; MALE; MORTALITY; MULTIVARIATE ANALYSIS; PREDICTION; PROBABILITY; PROGNOSIS; RISK ASSESSMENT; RISK FACTOR; ST SEGMENT ELEVATION;

EID: 33646396246     PISSN: 03008932     EISSN: None     Source Type: Journal    
DOI: 10.1157/13086077     Document Type: Article

References (33)

1. Marso SP, Ellis SG, Gurm HS, Lytle BW, Topol EJ. Proteinuria is a key determinant of death in patients with diabetes after isolated coronary artery bypass grafting. Am Heart J. 2000;139:939-44.
2. Marso SP, Ellis SG, Tuzcu M, Whitlow PL, Franco I, Raymond RE, et al. The importance of proteinuria as a determinant of mortality following percutaneous coronary revascularization in diabetics. J Am Coll Cardiol. 1999;33:1269-77.
3. McCullough PA, Wolyn R, Rocher LL, Levin RN, O'Neill WW. Acute renal failure after coronary intervention: incidence, risk factors, and relationship to mortality. Am J Med. 1997;103:368-75.
4. Dumaine R, Collet JP, Tanguy ML, Mansencal N, Dubois-Rande JL, Henry P, et al. Prognostic significance of renal insufficiency in patients presenting with acute coronary syndrome (the Prospective Multicenter SYCOMORE study). Am J Cardiol. 2004;94: 1543-7.
5. Hobbach HP, Gibson CM, Giugliano RP, Hundertmark J, Schaeffer C, Tscherleniak W, et al. The prognostic value of serum creatinine on admission in fibrinolytic-eligible patients with acute myocardial infarction. J Thromb Thrombolysis. 2003;16:167-74.
6. Al SJ, Reddan DN, Williams K, Pieper KS, Harrington RA, Califf RM, et al. Prognostic implications of abnormalities in renal function in patients with acute coronary syndromes. Circulation. 2002;106:974-80.
7. Freeman RV, Mehta RH, Al BW, Cooper JV, Kline-Rogers E, Eagle KA. Influence of concurrent renal dysfunction on outcomes of patients with acute coronary syndromes and implications of the use of glycoprotein IIb/ IIIa inhibitors. J Am Coll Cardiol. 2003; 41:718-24.
8. Masoudi FA, Plomondon ME, Magid DJ, Sales A, Rumsfeld JS. Renal insufficiency and mortality from acute coronary syndromes. Am Heart J. 2004;147:623-9.
9. Santopinto JJ, Fox KA, Goldberg RJ, Budaj A, Pinero G, Avezum A, et al. Creatinine clearance and adverse hospital outcomes in patients with acute coronary syndromes: findings from the global registry of acute coronary events (GRACE). Heart. 2003;89: 1003-8.
10. Walsh CR, O'Donnell CJ, Camargo CA Jr, Giugliano RP, Lloyd-Jones DM. Elevated serum creatinine is associated with 1-year mortality after acute myocardial infarction. Am Heart J. 2002; 144:1003-11.
11. Wison S, Foo K, Cunningham J, Cooper J, Deaner A, Knight C, et al. Renal function and risk stratification in acute coronary syndromes. Am J Cardiol. 2003;91:1051-4.
12. Januzzi JL, Cannon CP, DiBattiste PM, Murphy S, Weintraub W, Braunwald E. Effects of renal insufficiency on early invasive management in patients with acute coronary syndromes (The TACTICS-TIMI 18 Trial). Am J Cardiol. 2002;90:1246-9.
13. McCullough PA, Soman SS, Shah SS, Smith ST, Marks KR, Yee J, et al. Risks associated with renal dysfunction in patients in the coronary care unit. J Am Coll Cardiol. 2000;36:679-84.
14. Alpert JS, Thygesen K, Antman E, Bassand JP. Myocardial infarction redefined - a consensus document of The Joint European Society of Cardiology/American College of Cardiology Committee for the redefinition of myocardial infarction. J Am Coll Cardiol. 2000;36:959-69.
15. Anavekar NS, McMurray JJ, Velázquez EJ, Solomon SD, Kober L, Rouleau JL, et al. Relation between renal dysfunction and cardiovascular outcomes after myocardial infarction. N Engl J Med. 2004;351:1285-95.
16. Bodí V, Sanchís J, Llácer A, Fácila L, Núñez J, Pellicer M, et al. Indicadores pronósticos del síndrome coronario agudo sin elevación del segmento ST. Rev Esp Cardiol. 2003;56: 857-64.
17. Bodí V, Fácila L, Sanchís J, Llácer A, Núñez J, Mainar L, et al. Pronóstico a corto plazo de los pacientes ingresados por probable síndrome coronario agudo sin elevación del segmento ST. Papel de los nuevos marcadores de daño miocárdico y de los reactantes de fase aguda. Rev Esp Cardiol. 2002;55:823-30.
18. Sanchís J, Bodí V, Llácer A, Núñez J, Fácila L, Ruiz V, et al. Usefulness of C-reactive protein and left ventricular function for risk assessment in survivors of acute myocardial infarction. Am J Cardiol. 2004;94:766-9.
19. Bodí V, Sanchís J, Llácer A, Fácila L, Núñez J, Bertomeu V, et al. Risk stratification in non-ST elevation acute coronary syndromes: predictive power of troponin I, C-reactive protein, fibrinogen and homocysteine. Int J Cardiol. 2005; 98:277-83.
20. Levey AS, Bosch JP, Lewis JB, Greene T, Rogers N, Roth D. A more accurate method to estimate glomerular filtration rate from serum creatinine: a new prediction equation. Modification of Diet in Renal Disease Study Group. Ann Intern Med. 1999;130:461-70.
21. K/DOQI clinical practice guidelines for chronic kidney disease: evaluation, classification, and stratification. Am J Kidney Dis. 2002;39:S1-266.
22. D'Agostino RB, Pencina MJ. Overall C as a measure of discrimination in survival analysis: model specific population value and confidence interval estimation. Stat Med. 2005;23:2109-23.
23. Antman EM, Cohen M, Bernink PJ, McCabe CH, Horacek T, Papuchis G, et al. The TIMI risk score for unstable angina/non-ST elevation MI: A method for prognostication and therapeutic decision making. JAMA. 2000;284:835-42.
24. Al BW, Mukherjee D, Kline-Rogers E, Mani O, Hussain S, Mehta R, et al. Clinical association between renal insufficiency and positive troponin I in patients with acute coronary syndrome. Cardiology. 2004;102:215-9.
25. Launay-Vacher V, Izzedine H, Deray G. Using the right MDRD equation. Kidney Int. 2004;66:2089-90.
26. Fried LF, Shlipak MG, Crump C, Bleyer AJ, Gottdiener JS, Kronmal RA, et al. Renal insufficiency as a predictor of cardiovascular outcomes and mortality in elderly individuals. J Am Coll Cardiol. 2003;41:1364-72.
27. Gibson CM, Pinto DS, Murphy SA, Morrow DA, Hobbach HP, Wiviott SD, et al. Association of creatinine and creatinine clearance on presentation in acute myocardial infarction with subsequent mortality. J Am Coll Cardiol. 2003;42:1535-43.
28. Sarnak MJ, Levey AS, Schoolwerth AC, Coresh J, Culleton B, Hamm LL, et al. Kidney disease as a risk factor for development of cardiovascular disease: a statement from the American Heart Association Councils on Kidney in Cardiovascular Disease, High Blood Pressure Research, Clinical Cardiology, and Epidemiology and Prevention. Circulation. 2003;108:2154-69.
29. Levey AS, Beto JA, Coronado BE, Eknoyan G, Foley RN, Kasiske BL, et al. Controlling the epidemic of cardiovascular disease in chronic renal disease: what do we know? What do we need to learn? Where do we go from here? National Kidney Foundation Task Force on Cardiovascular Disease. Am J Kidney Dis. 1998; 32:853-906.
30. Jungers P, Massy ZA, Khoa TN, Fumeron C, Labrunie M, Lacour B, et al. Incidence and risk factors of atherosclerotic cardiovascular accidents in predialysis chronic renal failure patients: a prospective study. Nephrol Dial Transplant. 1997;12:2597-602.
31. Berger AK, Duval S, Krumholz HM. Aspirin, beta-blocker, and angiotensin-converting enzyme inhibitor therapy in patients with end-stage renal disease and an acute myocardial infarction. J Am Coll Cardiol. 2003;42:201-8.
32. Shlipak MG, Heidenreich PA, Noguchi H, Chertow GM, Browner WS, McClellan MB. Association of renal insufficiency with treatment and outcomes after myocardial infarction in elderly patients. Ann Intern Med. 2002;137:555-62.
33. McCullough PA, Sandberg KR, Borzak S, Hudson MP, Garg M, Manley HJ. Benefits of aspirin and beta-blockade after myocardial infarction in patients with chronic kidney disease. Am Heart J. 2002;144:226-32.